Kurelac I.; MacKay A.; Lambros M.B.K.; Di Cesare E.; Cenacchi G.; Ceccarelli C.; Morra I.; Melcarne A.; Morandi L.; Calabrese F.M.; Attimonelli M.; Tallini G.; Reis-Filho J.S.; Gasparre G., Somatic mitochondrial DNA disruptive mutations are modifiers of tumourigenesis that correlate with low genomic instability in pituitary adenomas, «HUMAN MOLECULAR GENETICS», 2013, 22(2), pp. 226 - 238 [articolo]
Bernstein JI; Virk R; Hui P; Prasad A; Westra WH; Tallini G; Adeniran AJ; Udelsman R; Sasaki CT; Roman S; Sosa JA; Prasad ML, Tall Cell Variant of Papillary Thyroid Microcarcinoma: Clinicopathological Features with BRAFV600E Mutational Analysis, «THYROID», 2013, 23, pp. 1525 - 1531 [articolo]
Pradella L.M.; Lang M.; Kurelac I.; Mariani E.; Guerra F.; Zuntini R.; Tallini G.; MacKay A.; Reis-Filho J.S.; Seri M.; Turchetti D.; Gasparre G., Where Birt-Hogg-Dubé meets Cowden Syndrome: Mirrored genetic defects in two cases of syndromic oncocytic tumours, «EUROPEAN JOURNAL OF HUMAN GENETICS», 2013, 21, pp. 1169 - 1172 [articolo]
Altimari A; de Biase D; De Maglio G; Gruppioni E; Capizzi E; Degiovanni A; D'Errico A; Pession A; Pizzolitto S; Fiorentino M; Tallini G., 454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples, «ONCOTARGETS AND THERAPY», 2013, 6, pp. 1057 - 1064 [articolo]
Morandi L.; de Biase D.; Visani M.; Cesari V.; De Maglio G.; Pizzolitto S.; Pession A.; Tallini G., Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation., «PLOS ONE», 2012, 7, Article number: e36084, pp. 1 - 13 [articolo]Open Access
F.C. Geyer; D. de Biase; M.B.K. Lambros; M. Ragazzi; M.A. Lopez-Garcia; R. Natrajan; A. Mackay; I. Kurelac; G. Gasparre; A. Ashworth; V. Eusebi; J.S. Reis-Filho; G. Tallini, Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology, «BREAST CANCER RESEARCH AND TREATMENT», 2012, 132(1), pp. 15 - 28 [articolo]
Caria P.; Dettori T.; Frau D.V.; Di Oto E.; Morandi L.; Parmeggiani A.; Tallini G.; Vanni R., Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma., «THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY», 2012, 36, pp. 1415 - 1420 [articolo]
Morandi L.; de Biase D.; Visani M.; Monzoni A.; Tosi A.; Brulatti M.; Turchetti D.; Baccarini P.; Tallini G.; Pession A., T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer, «INTERNATIONAL JOURNAL OF COLORECTAL DISEASE», 2012, 27, pp. 647 - 656 [articolo]
Durante C.; Tallini G.; Puxeddu E.; Sponziello M.; Moretti S.; Ligorio C.; Cavaliere A.; Rhoden K.; Verrienti A.; Maranghi M.; Giacomelli L.; Russo D.; Filetti S., BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas., «EUROPEAN JOURNAL OF ENDOCRINOLOGY», 2011, 165, pp. 455 - 463 [articolo]
Piana S; Frasoldati A; Di Felice E; Gardini G; Tallini G; Rosai J., Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma, «THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY», 2011, 35, pp. 314 - 314 [replica/breve intervento]
Cremonini N.; Tallini G.; Crescenzi A., Esami Genetici, in: Manuale per la Valutazione e l’inquadramento delle Patologie della Tiroide., VERONA, AME SCRIPTA S.C. VERONA, 2011, pp. 215 - 224 [capitolo di libro]
Tallini G.; Gallo C., Fine-needle aspiration and intraoperative consultation in thyroid pathology: when and how?, «INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY», 2011, 19, pp. 141 - 144 [articolo]
Moira Ragazzi;Dario de Biase;Christine M. Betts;Anna Farnedi;Saime Sezgin Ramadan;Giovanni Tallini;Jorge S. Reis-Filho;Vincenzo Eusebi, Oncocytic carcinoma of the breast: frequency, morphology and follow-up, «HUMAN PATHOLOGY», 2011, 42, pp. 166 - 175 [articolo]
Tallini G., Poorly differentiated thyroid carcinoma. Are we there yet?, «ENDOCRINE PATHOLOGY», 2011, 22, pp. 190 - 194 [articolo]
Voce P.; D'Agostino M.; Moretti S.; Sponziello M.; Rhoden K.; Calcinaro F.; Tamburrano G.; Tallini G.; Puxeddu E.; Filetti S.; Russo D.; Durante C., Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors., «ONCOLOGY REPORTS», 2011, 26, pp. 1075 - 1080 [articolo]
